BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 25524791)

  • 1. Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA).
    Fernández de la Cruz L; Simonoff E; McGough JJ; Halperin JM; Arnold LE; Stringaris A
    J Am Acad Child Adolesc Psychiatry; 2015 Jan; 54(1):62-70.e3. PubMed ID: 25524791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.
    Arch Gen Psychiatry; 1999 Dec; 56(12):1088-96. PubMed ID: 10591284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
    Arch Gen Psychiatry; 1999 Dec; 56(12):1073-86. PubMed ID: 10591283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Treatment Outcomes of Persistent Negative Mood Among Children with Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior.
    Blader JC; Pliszka SR; Kafantaris V; Sauder C; Posner J; Foley CA; Carlson GA; Crowell JA; Margulies DM
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):164-73. PubMed ID: 26745211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study.
    Ricketts EJ; Sturm A; McMakin DL; McGuire JF; Tan PZ; Smalberg FB; McCracken JT; Colwell CS; Piacentini J
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):690-698. PubMed ID: 30388029
    [No Abstract]   [Full Text] [Related]  

  • 7. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.
    Gadow KD; Arnold LE; Molina BS; Findling RL; Bukstein OG; Brown NV; McNamara NK; Rundberg-Rivera EV; Li X; Kipp HL; Schneider J; Farmer CA; Baker JL; Sprafkin J; Rice RR; Bangalore SS; Butter EM; Buchan-Page KA; Hurt EA; Austin AB; Grondhuis SN; Aman MG
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):948-959.e1. PubMed ID: 25151418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral parent training as an adjunct to routine care in children with attention-deficit/hyperactivity disorder: moderators of treatment response.
    van den Hoofdakker BJ; Nauta MH; van der Veen-Mulders L; Sytema S; Emmelkamp PM; Minderaa RB; Hoekstra PJ
    J Pediatr Psychol; 2010 Apr; 35(3):317-26. PubMed ID: 19633060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.
    Winters DE; Fukui S; Leibenluft E; Hulvershorn LA
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):298-305. PubMed ID: 29708762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telephone-assisted self-help for parents of children with attention-deficit/hyperactivity disorder who have residual functional impairment despite methylphenidate treatment: a randomized controlled trial.
    Dose C; Hautmann C; Buerger M; Schuermann S; Woitecki K; Doepfner M
    J Child Psychol Psychiatry; 2017 Jun; 58(6):682-690. PubMed ID: 27878809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
    Hazell P
    Australas Psychiatry; 2010 Dec; 18(6):556-9. PubMed ID: 21117844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive function in children with disruptive mood dysregulation disorder compared to attention-deficit/hyperactivity disorder and oppositional defiant disorder, and in children with different irritability levels.
    Brænden A; Coldevin M; Zeiner P; Stubberud J; Melinder A
    Eur Child Adolesc Psychiatry; 2024 Jan; 33(1):115-125. PubMed ID: 36680626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In the wake of the MTA: charting a new course for the study and treatment of children with attention-deficit hyperactivity disorder.
    Cunningham CE
    Can J Psychiatry; 1999 Dec; 44(10):999-1006. PubMed ID: 10637679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers.
    Jensen PS; Hinshaw SP; Swanson JM; Greenhill LL; Conners CK; Arnold LE; Abikoff HB; Elliott G; Hechtman L; Hoza B; March JS; Newcorn JH; Severe JB; Vitiello B; Wells K; Wigal T
    J Dev Behav Pediatr; 2001 Feb; 22(1):60-73. PubMed ID: 11265923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-year follow-up of the NIMH MTA study.
    Jensen PS; Arnold LE; Swanson JM; Vitiello B; Abikoff HB; Greenhill LL; Hechtman L; Hinshaw SP; Pelham WE; Wells KC; Conners CK; Elliott GR; Epstein JN; Hoza B; March JS; Molina BSG; Newcorn JH; Severe JB; Wigal T; Gibbons RD; Hur K
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):989-1002. PubMed ID: 17667478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
    Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
    JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit hyperactivity disorder, multimodal treatment, and longitudinal outcome: evidence, paradox, and challenge.
    Hinshaw SP; Arnold LE;
    Wiley Interdiscip Rev Cogn Sci; 2015; 6(1):39-52. PubMed ID: 26262927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.